Effects of naloxone on breathing movements during hypercapnia in the fetal lamb.
To determine whether endogenous opioids influence the fetal breathing response to CO2 we have investigated the effect of the opiate antagonist, naloxone on the incidence, rate, and amplitude of breathing movements during hypercapnia in fetal lambs in utero. In 20 experiments in six pregnant sheep (130-145 days gestation) hypercapnia was induced by giving the ewe 4-6% CO2-18% O2 in N2 to breathe for 60 min. After 30 min of hypercapnia either naloxone (13 experiments) or saline (7 experiments) was infused intravenously for the remaining 30 min. During hypercapnia breath amplitude increased from 5.8 +/- 0.5 to 9.1 +/- 1.2 mmHg (P less than 0.001), and infusion of naloxone was associated with a further significant increase to 15.7 +/- 1.2 mmHg (P less than 0.001). Naloxone had no effect on the incidence or rate of breathing movements during hypercapnia. After hypercapnia there was a significant decrease in the incidence of fetal breathing movements in the naloxone group (14.7 +/- 3.2%). Infusion of saline during hypercapnia had no effect on incidence, rate, or amplitude of fetal breathing movements. These results suggest that endogenous opioids act to suppress or limit breath amplitude during hypercapnia but do not affect rate or incidence of breathing movements.
D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D004562:Electrocardiography; D004576:Electromyography; D005260:Female; D005324:Fetal Movement / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D006935:Hypercapnia / Q000196:embryology / Q000503:physiopathology*; D009270:Naloxone / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D011247:Pregnancy; D012119:Respiration / Q000187:drug effects*; D012756:Sheep
D002245:Carbon Dioxide; D009270:Naloxone; D010100:Oxygen